Inventor · White Plains, NY, US

Kara Olson

15Patents

3h-index

23Co-inventors

56Inventor score

Filing activity: Sep 18, 2008 → Feb 15, 2024

Most-cited inventions

Patent	Title	Area	Cited by	Status
US8586713B2	Readily isolated bispecific antibodies with native immunoglobulin format	Chemistry; Metallurgy	149	Active
US11384153B2	Bispecific anti-BCMA x anti-CD3 antibodies and uses thereof	Chemistry; Metallurgy	4	Active
US11396544B2	Bispecific anti-CD28 × anti-CD22 antibodies and uses thereof	Chemistry; Metallurgy	4	Active
US8268311B2	Human GM-CSF antigen binding proteins	Chemistry; Metallurgy	3	Active
US9309326B2	Readily isolated bispecific antibodies with native immunoglobulin format	Chemistry; Metallurgy	3	Active
US11168111B2	Readily isolated bispecific antibodies with native immunoglobulin format	Chemistry; Metallurgy	2	Active
US9982013B2	Readily isolated bispecific antibodies with native immunoglobulin format	Chemistry; Metallurgy	2	Active
US11937587B2	Non-human animals expressing humanized CD3 complex	Emerging Cross-Sectional Technologies	0	Active
US8481704B2	Nucleic acid molecule encoding human GM-CSF antigen binding proteins	Chemistry; Metallurgy	0	Active
US12157758B2	Readily isolated bispecific antibodies with native immunoglobulin format	Chemistry; Metallurgy	0	Active
US12419282B2	Non-human animals expressing humanized CD3 complex	Emerging Cross-Sectional Technologies	0	Active
US12258412B2	Nucleic acid molecules encoding bispecific anti-BCMA x anti-CD3 antibodies	Chemistry; Metallurgy	0	Active
US11905332B2	Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof	Chemistry; Metallurgy	0	Active
US12274747B2	Compositions and methods for treating cytokine release syndrome	Chemistry; Metallurgy	0	Active
US10932455B2	Non-human animals expressing humanized CD3 complex	Emerging Cross-Sectional Technologies	0	Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.